The Association Between Oral Mucosal Lesions and Oral Health-Related Quality of Life Using the Validated Indonesian Version of OHIP-14 Among People Living with HIV/AIDS

References

• Tappuni AR. The global changing pattern of the oral manifestations of HIV. Oral Dis. 2020;26(S1):22–27. doi:10.1111/odi.13469
   PubMedGoogle Scholar
• Sharma G, Oberoi SS, Vohra P, Nagpal A. Oral manifestations of HIV/AIDS in Asia: systematic review and future research guidelines. J Clin Exp Dent. 2015;7(3):e419–e427. doi:10.4317/jced.52127
   PubMedGoogle Scholar
• Umeizudike KA, Osagbemiro BB, Daramola OO, Adeyemo TA. Oral health related quality of life among HIV positive patients attending two HIV outpatient clinics in Nigeria - a cross sectional study. Afr Health Sci. 2021;21(2):566–575. doi:10.4314/ahs.v21i2.11
   PubMed Web of Science ®Google Scholar
• Lomelí-Martínez SM, González-Hernández LA, de Ruiz-Anaya AJ, et al. Oral Manifestations Associated with HIV/AIDS Patients. Medicina. 2022;58(9):1214. doi:10.3390/medicina58091214
   PubMedGoogle Scholar
• Bennadi D, Reddy CVK. Oral health related quality of life. J Int Soc Prev Community Dent. 2013;3(1):1–6. doi:10.4103/2231-0762.115700
   PubMedGoogle Scholar
• Campos LA, Peltomäki T, Marôco J, Campos JADB. Use of oral health impact profile-14 (OHIP-14) in different contexts. What is being measured? Int J Environ Res Public Health. 2021;18(24):13412. doi:10.3390/ijerph182413412
   PubMed Web of Science ®Google Scholar
• Mohamed N, Saddki N, Yusoff A, Mat Jelani A. Association among oral symptoms, oral health-related quality of life, and health-related quality of life in a sample of adults living with HIV/AIDS in Malaysia. BMC Oral Health. 2017;17(1):1–11. doi:10.1186/s12903-017-0409-y
   Google Scholar
• Denny CE, Ramapuram J, Bastian TS, Ongole R, Binnal A, Natarajan S. Oral lesions in HIV/AIDS patients on highly active antiretroviral therapy. World J Dent. 2016;7(2):95–99. doi:10.5005/jp-journals-10015-1373
   Google Scholar
• Rosa DE, Sufiawati I. Case Series of HIV-associated oral lesions among antiretroviral-naive patients during the COVID-19 pandemic. Int Med Case Rep J. 2023;16:73–82. doi:10.2147/IMCRJ.S398736
   PubMed Web of Science ®Google Scholar
• Novianti Y, Sufiawati I. Clinical assessment and management in improving the quality of life of HIV/AIDS patients with oral candidiasis: a case series. HIV AIDS. 2023;15:683–696. doi:10.2147/HIV.S434175
   Google Scholar
• Bajomo AS, Ayo-Yusuf OA, Rudolph MJ, Tsotsi NM. Impact of oral lesions among South African adults with HIV/AIDS on oral health-related quality of life. J Dent Sci. 2013;8(4):412–417. doi:10.1016/j.jds.2013.04.011
   Web of Science ®Google Scholar
• Hoffman M, Chansky PB, Bashyam AR, et al. Long-term physical and psychological outcomes of Stevens-Johnson syndrome/toxic epidermal necrolysis. JAMA dermatol. 2021;157(6):712–715. doi:10.1001/jamadermatol.2021.1136
   PubMed Web of Science ®Google Scholar
• Cekic S, Canitez Y, Yuksel H, et al. A comprehensive assessment of long-term complications in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. Int Arch Allergy Immunol. 2023;184(10):994–1002. doi:10.1159/000531366
   PubMed Web of Science ®Google Scholar
• Rovaris NS, Galato D, Schuelter-Trevisol F, et al. Oral health status and its impact on the quality of life of children and adolescents living with HIV-1. BMC Res Notes. 2014;7(1):1–7. doi:10.1186/1756-0500-7-478
   PubMedGoogle Scholar
• Liberali SA, Coates EA, Freeman AD, Logan RM, Jamieson L, Mejia G. Oral conditions and their social impact among HIV dental patients, 18 years on. Aust Dent J. 2013;58. doi:10.1111/adj.12031
   Web of Science ®Google Scholar
• Mary EO, Abiola OA, Titilola G, Mojirayo OO, Sulaimon AA. Prevalence of HIV related oral lesions in people living with HIV and on combined antiretroviral therapy: a Nigerian experience. Pan Afr Med J. 2018;31:1–10. doi:10.11604/pamj.2018.31.180.13574
   PubMedGoogle Scholar
• Batavia AS, Secours R, Espinosa P, Jean Juste MA, Severe P, Pape JW. Diagnosis of HIV-associated oral lesions in relation to early versus delayed antiretroviral therapy: results from the CIPRA HT001 trial. PLoS One. 2016;11. doi:10.1371/journal.pone.0150656
   Google Scholar
• Villanueva-Vilchis M-C, López-Ríos P, García I-M, Gaitán-Cepeda L-A. Impact of oral mucosa lesions on the quality of life related to oral health. An etiopathogenic study. Med Oral Patol Oral Cir Bucal. 2016;21(2):e178–e184. doi:10.4317/medoral.20866
   PubMed Web of Science ®Google Scholar
• Zucoloto ML, Maroco J, Campos JADB. Impact of oral health on health-related quality of life: a cross-sectional study. BMC Oral Health. 2016;16(1):2–7. doi:10.1186/s12903-016-0211-2
   PubMedGoogle Scholar
• Hosain Pour A, Salari S, Ghasemi Nejad Almani P. Oropharyngeal candidiasis in HIV/AIDS patients and non-HIV subjects in the Southeast of Iran. Curr Med Mycol. 2018;4(4):1–6. doi:10.18502/cmm.4.4.379
   PubMedGoogle Scholar
• Hasegawa A, Abe R. Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis [version 1; peer review: 2 approved]. F1000Research. 2020;9(612). doi:10.12688/f1000research.24748.1
   PubMedGoogle Scholar
• Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T. Current perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis. Clin Rev Allergy Immunol. 2018;54(1):147–176. doi:10.1007/s12016-017-8654-z
   PubMed Web of Science ®Google Scholar
• Knight L, Muloiwa R, Dlamini S, Lehloenya RJ. Factors associated with increased mortality in a predominantly HIV-infected population with Stevens Johnson syndrome and toxic epidermal necrolysis. PLoS One. 2014;9(4):e93543. doi:10.1371/journal.pone.0093543
   PubMed Web of Science ®Google Scholar
• Chateau AV, Dlova NC, Dawood H, Aldous C. Outcomes of Stevens–Johnson syndrome and toxic epidermal necrolysis in HIV-infected patients when using systemic steroids and/or intravenous immunoglobulins in Pietermaritzburg, South Africa. South Afr J HIV Med. 2019;20(1):1–8. doi:10.4102/sajhivmed.v20i1.944
   Google Scholar